BioPharma Dive November 21, 2024
Venture capital firms incubate, grow and finance dozens of new drug companies each year. Follow the money they channel into the industry with this database.
Drug development is an expensive, risky endeavor. Biotechnology companies just starting out are many years away from seeing profits, if ever. So more often than not, a startup’s success turning science into medicines can come down to how much money it raises. That’s where venture capitalists step in, investing many millions of dollars for stakes in newly formed companies.
Young drugmakers rely on these private partners to survive until they can reach major milestones like entering clinical testing, or going public. And over the past two decades, they’ve had more and more help. The amount...
Today's Sponsors
Today's Sponsor